Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial (Q43733116)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial |
scientific article |
Statements
1 reference
Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial (English)
1 reference
Sydney Bonnick
1 reference
Tobias De Villiers
1 reference
Alberto Odio
1 reference
Santiago Palacios
1 reference
Roland Chapurlat
1 reference
Carolyn DaSilva
1 reference
Boyd B Scott
1 reference
Celine Le Bailly De Tilleghem
1 reference
Albert T Leung
1 reference
Deborah Gurner
1 reference
24 September 2013
1 reference
1 reference
98
1 reference
12
1 reference
4727-4735
1 reference
Identifiers
1 reference
1 reference